CELZ.US Creative Medical Technology Holdings Inc

Healthcare Biotechnology USA Stocks
0.5281 USD
Close of Nov 14, 2026
0.5281 3.22
Market cap
USD 4.01M
P/E
-
P/B
0.54x
ROE
-107.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CELZ.US undervalued?

Graham number

The Graham number of Creative Medical Technology Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Creative Medical Technology Holdings Inc fundamental analysis

No fundamental analysis for Creative Medical Technology Holdings Inc yet.

Creative Medical Technology Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100),…

Full company profile